Regulation of Lens Fiber Cell Organization
晶状体纤维细胞组织的调节
基本信息
- 批准号:8487408
- 负责人:
- 金额:$ 34.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Lens transparency is made possible by a combination of the highly ordered organization of the lens fiber cells, their unique refractive index, and the lack of organelles in the fiber cells. The highly ordered arrangement of the lens fiber cells is critical for proper light transmission, and disruption of this structure by alterations of cell-cell interactions is likely to lead to cataracts. However, signals that regulate lens fiber cell interaction remain largely unknown. Our preliminary studies have identified a new class of molecules, the Eph tyrosine kinase receptor family that regulates lens cell organization. Inactivation of ephrin-A5, a ligand of the Eph receptors, leads to the disruption of N-cadherin localization, change in lens fiber cell shape, disorganization of lens cells, and the development of cataracts. We hypothesize that ephrin-A5, interacting with its receptor(s), regulates N-cadherin-mediated fiber cell adhesion to maintain proper lens cell organization. To test this hypothesis, we will: (1) Examine the spatial and temporal characteristics of the ephrin-A5-null lens, determine when and where during development the lens defects first occur, and whether the loss of ephrin-A5 results in disruptions of lens fiber cell differentiation. The morphology of the lens at different developmental stages will be analyzed using both light and electron microscope techniques. Antibodies against markers of lens cell differentiation will be used in immunohistochemical experiments to study the expression of differentiation markers. (2) Elucidate receptor mechanisms of ephrin-A5 in lens development by examining which specific Eph receptors are expressed in the developing lens and where they are expressed, using Real-Time PCR, in situ hybridization, and immunohistochemistry. Since the interaction between Eph receptors and ligands leads to bidirectional signaling, we plan to analyze whether receptor- mediated signaling, the ligand-mediated reverse signaling or both are required for lens development using selective inactivation of different receptor domains. (3) Study the molecular alterations that lead to cataracts in ephrin-A5-null mice. Preliminary studies have revealed a disruption of N-cadherin distribution in the lens fiber cells. We will determine whether ephrin-A5 receptors interact physically with adherens junction molecules, and analyze effects of the ligand on N-cadherin functions. To critically evaluate roles of N-cadherin in mediating ephrin-A5 function and lens cell adhesion, we plan also to examine expression of a N-cadherin-2-catenin fusion protein in a phenotypic rescue experiment. The proposed studies will establish roles of a previously unsuspected family of molecules in lens development and reveal novel regulations of N-cadherin functions. These studies will enhance our understanding of how lens cell interaction is regulated to ensure lens transparency and provide insights into the mechanisms of cataractogenesis.
描述(由申请人提供):透镜透明度是通过晶状体纤维细胞的高度有序组织,其独特的折射率以及纤维细胞中缺乏细胞器的组合来实现的。透镜纤维电池的高度有序排列对于适当的光传输至关重要,并且通过细胞 - 细胞相互作用的改变来破坏这种结构可能导致白内障。但是,调节透镜纤维相互作用的信号在很大程度上尚不清楚。我们的初步研究已经确定了一种新的分子,即调节晶状体细胞组织的EPH酪氨酸激酶受体家族。 EPHRIN-A5(EPH受体的配体)的失活导致N-钙粘蛋白定位的破坏,透镜纤维细胞形状的变化,透镜细胞的混乱和白内障的发展。我们假设ephrin-A5与其受体相互作用,调节N-钙粘蛋白介导的纤维细胞粘附以保持适当的晶状体细胞组织。为了检验这一假设,我们将:(1)检查晶状体A5-NULL透镜的空间和时间特征,确定在发育期间何时何地出现镜头缺陷,以及ephrin-A5的丧失是否导致透镜纤维细胞分化的破坏。将使用光和电子显微镜技术分析不同发育阶段的镜头的形态。针对晶状体细胞分化标记的抗体将用于免疫组织化学实验,以研究分化标记的表达。 (2)通过检查在发育中的晶状体中表达哪些特异性EPH受体以及使用实时PCR,原位杂交和免疫组织化学表达的特定EPH受体,从而阐明了晶状体发育中Ephrin-A5的受体机制。由于EPH受体和配体之间的相互作用导致双向信号传导,因此我们计划分析受体介导的信号传导,配体介导的反向信号传导是否需要使用不同受体结构域的选择性失活晶状体开发。 (3)研究导致ephrin-A5-Null小鼠白内障的分子改变。初步研究表明,晶状体纤维细胞中N-钙粘蛋白分布的破坏。我们将确定ephrin-A5受体是否与粘附分子进行物理相互作用,并分析配体对N-钙粘蛋白功能的影响。为了批判性评估N-钙粘蛋白在介导Ephrin-A5功能和透镜细胞粘附中的作用,我们还计划在表型救援实验中检查N-钙粘蛋白-2-catenin融合蛋白的表达。拟议的研究将在晶状体发育中建立先前未经引起的分子家族的作用,并揭示N-钙粘蛋白功能的新法规。这些研究将增强我们对晶状体细胞相互作用的调节方式的理解,以确保晶状体透明度并提供有关白内生生成机制的见解。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
人类白内障 EPHA2 SAM 结构域突变改变受体稳定性和功能
- DOI:10.1371/journal.pone.0036564
- 发表时间:2012
- 期刊:
- 影响因子:3.7
- 作者:Park JE;Son AI;Hua R;Wang L;Zhang X;Zhou R
- 通讯作者:Zhou R
Roles of EphA2 in Development and Disease.
- DOI:10.3390/genes4030334
- 发表时间:2013-07-01
- 期刊:
- 影响因子:3.5
- 作者:Park JE;Son AI;Zhou R
- 通讯作者:Zhou R
The role of Eph receptors in lens function and disease.
- DOI:10.1007/s11427-012-4318-7
- 发表时间:2012-05
- 期刊:
- 影响因子:9.1
- 作者:Son, Alexander, I;Park, Jeong Eun;Zhou RenPing
- 通讯作者:Zhou RenPing
共 3 条
- 1
RENPING ZHOU的其他基金
Regulation of Lens Fiber Cell Organization
晶状体纤维细胞组织的调节
- 批准号:82816038281603
- 财政年份:2009
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
Regulation of Lens Fiber Cell Organization
晶状体纤维细胞组织的调节
- 批准号:80912518091251
- 财政年份:2009
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
Regulation of Lens Fiber Cell Organization
晶状体纤维细胞组织的调节
- 批准号:77285077728507
- 财政年份:2009
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
Regulation of Lens Fiber Cell Organization
晶状体纤维细胞组织的调节
- 批准号:78766727876672
- 财政年份:2009
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
EPH FAMILY RECEPTORS IN THE HIPPOCAMPOSEPTAL SYSTEM
海马中隔系统中的 EPH 家族受体
- 批准号:65723336572333
- 财政年份:2002
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
EPH FAMILY RECEPTORS IN THE HIPPOCAMPOSEPTAL SYSTEM
海马中隔系统中的 EPH 家族受体
- 批准号:63019396301939
- 财政年份:2000
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
EPH FAMILY RECEPTORS IN THE HIPPOCAMPOSEPTAL SYSTEM
海马中隔系统中的 EPH 家族受体
- 批准号:61084866108486
- 财政年份:1999
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
EPH MOLECULES IN OTOGENY OF BRAIN REWARD CIRCUITS
EPH 分子在大脑奖赏电路发育中的作用
- 批准号:63422736342273
- 财政年份:1998
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
EPH MOLECULES IN OTOGENY OF BRAIN REWARD CIRCUITS
EPH 分子在大脑奖赏电路发育中的作用
- 批准号:24545662454566
- 财政年份:1998
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
EPH MOLECULES IN OTOGENY OF BRAIN REWARD CIRCUITS
EPH 分子在大脑奖赏电路发育中的作用
- 批准号:61378166137816
- 财政年份:1998
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Treatment of Alzheimer’s Disease using Ultrasound-Targeted Microbubble Cavitation-Mediated Blood Brain Barrier Opening to Facilitate Drug Delivery to the Brain
使用超声靶向微泡空化介导的血脑屏障打开促进药物输送至大脑来治疗阿尔茨海默病
- 批准号:1046203710462037
- 财政年份:2022
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
Treatment of Alzheimer’s Disease using Ultrasound-Targeted Microbubble Cavitation-Mediated Blood Brain Barrier Opening to Facilitate Drug Delivery to the Brain
使用超声靶向微泡空化介导的血脑屏障打开促进药物输送到大脑来治疗阿尔茨海默病
- 批准号:1071037310710373
- 财政年份:2022
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
The Therapeutic Potential of Cold Stored Platelets in Regulating Vascular Instability in Trauma
冷藏血小板调节创伤血管不稳定的治疗潜力
- 批准号:1003515710035157
- 财政年份:2020
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
The Therapeutic Potential of Cold Stored Platelets in Regulating Vascular Instability in Trauma
冷藏血小板调节创伤血管不稳定的治疗潜力
- 批准号:1043866010438660
- 财政年份:2020
- 资助金额:$ 34.3万$ 34.3万
- 项目类别:
The Therapeutic Potential of Cold Stored Platelets in Regulating Vascular Instability in Trauma
冷藏血小板调节创伤血管不稳定的治疗潜力
- 批准号:1022953510229535
- 财政年份:2020
- 资助金额:$ 34.3万$ 34.3万
- 项目类别: